Skip to main content
Log in

Effect of Gastrin and Anti-Gastrin Antibodies on Proliferation of Hepatocyte Cell Lines

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Gastrin (G-17) and its precursor glycine-extended gastrin (G-17-gly) have been shown to be trophic to some gastrointestinal tumors. This in vitro study assessed the effect of G-17, G-17-gly, anti-gastrin antibodies (anti-G-17), and the CCK-B receptor antagonist PD135,158 on three hepatoma cell lines (PLC/PRF/5, HepG2 and MCA-RH7777) and an embryonic liver cell line (WRL68). The pancreatic adenocarcinoma cell line AR42J was used as a positive control. G-17 and G-17-gly caused significant proliferation of AR42J and WRL68 cell lines. G-17-gly but not G-17 induced significant proliferation of the PLC/PRF/5 cell line. Anti-G-17 and PD135,158 significantly inhibited unstimulated AR42J and WRL68 cell lines. Anti-G-17 also inhibited the proliferative effects of G-17 and G-17-gly on AR42J, WRL68, and PLC/PRF/5 cell lines, whereas PD135,158 inhibited the proliferative effect of G-17 only. G-17 and G-17-gly as well as anti-G-17 and PD135,158 had no effect on HepG2 and MCA-RH77777 cell lines. It is concluded that G-17-stimulated proliferation is mediated via the CCK-B receptor and G-17-gly via a separate, as yet uncharacterized, receptor. There may therefore be a role for gastrin in embryonic hepatocellular proliferation and perhaps also in the proliferation of some hepatocellular tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wolfe MM, Soll AH. Physiology of gastric acid secretion: N Engl J Med 319:1707–1715, 1988

    Google Scholar 

  2. Sugano K, Aponte GW, Yamada T: Identification and characterisation of glycine-extended post-translational processing intermediates of progastrin in porcine stomach. J Biochem 260:11724–11729, 1985

    Google Scholar 

  3. Delvalle J, Sugano K, Yamada T: Progastrin and its glycineextended posttranslational processing intermediates in human gastrointestinal tissues. Gastroenterology 92:1908–1912, 1987

    Google Scholar 

  4. Johnson LR. Regulation of gastrointestinal growth. In Physiology of the Gastrointestinal Tract. LR Johnson, J Christensen, MI Grossman, ED Jacobson, SG Schultz (eds). New York, Raven Press, 1981, pp 169–196

    Google Scholar 

  5. Townsend CM, Beauchamp RD, Singh P, Thompson JC: Growth factors and intestinal neoplasms. Am J Surg 155:526–536, 1988

    Google Scholar 

  6. Winsett OE, Townsend CM, Glass EJ, Thompson JC: Gastrin stimulates the growth of colon cancer. Surgery 99:302–307, 1986

    Google Scholar 

  7. Ciccotosto GD, McLeish A, Hardy KJ, Shulkes A: Expression, processing and secretion of gastrin in patients with colorectal carcinoma. Gastroenterology 109:1142–1153, 1995

    Google Scholar 

  8. Smith JP, Shih A, Wu Y, McLaughlin P, Zagon I. Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion. Am J Physiol 270:R1078–R1084, 1996

    Google Scholar 

  9. Rehfeld JF, Bardram L, Hilsted L: Gastrin in human bronchogenic carcinomas: Constant expression but variable processing of progastrin. Cancer Res 49:2840–2843, 1989

    Google Scholar 

  10. Blackmore M, Doherty E, Manning JE, Hirst BH: Autocrine growth stimulation of human Wilms tumour G401 cells by a gastrin-like peptide. Int J Cancer 57:385–391, 1994

    Google Scholar 

  11. Seva C, Dickinson CJ, Yamada T: Growth-promoting effects of glycine-extended progastrin. Science 265:410–412, 1994

    Google Scholar 

  12. Singh P, Xu Z, Dai B, Rajaraman S, Rubin N, Dhruva B: Incomplete processing of progastrin expressed by human colon cancer cells: A role of noncarboxyamidated gastrins. Am J Physiol 266:G459–G468, 1994

    Google Scholar 

  13. Singh P, Owlia A, Varro A, Dai B, Rajaraman S, Wood T: Gastrin gene expression is required for the proliferation and tumorigenicity of human colon cancer cells. Cancer Res 56:4111–4115, 1996

    Google Scholar 

  14. Van Sollinge WW, Nielsen FC, Friis-Hansen L, Falkmer UG, Rehfeld JF: Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterology 104:1099–1107, 1993

    Google Scholar 

  15. Hoosein NM, Keiner PA, Curry RC, Brattain MG: Evidence for autocrine growth stimulation of cultured colon tumour cells by a gastrin/cholecystokinin-like peptide. Exp Cell Res 186:15–21, 1990

    Google Scholar 

  16. Negre F, Fagot-Revurat P, Boisson M, Rehfeld JF, Vaysse N, Pradayrol L: Autocrine stimulation of AR4-2J rat pancreatic tumor cell growth by glycine-extended gastrin. Int J Cancer 66:653–658, 1996

    Google Scholar 

  17. Strunz U, Thompson MR, Elashoff J, Grossman MI: Hepatic inactivation of gastrins of various chain lengths in dogs. Gastroenterology 74:550–553, 1978

    Google Scholar 

  18. Christiansen LA: The metabolism of gastrin-34, gastrin-17 and gastrin-14 in the isolated perfused pig liver. Scand J Gastroenterol 19:131–138, 1984

    Google Scholar 

  19. Yao CZ, Bold RJ, Ishizuka J, Townsend CM Jr, Thompson JC: Growth of mouse hepatocytes is stimulated by gastrin. J Cell Physiol 163(3):532–537, 1995

    Google Scholar 

  20. Rasmussen TN, Jorgensen PE, Almdal T, Poulson SS, Olsen PS: Effect of gastrin on liver regeneration after partial hepatectomy in rats. Gut 31:92–95, 1990

    Google Scholar 

  21. Chen D, Ding XQ, Rehfeld JF, Hakanson R: Endogenous gastrin and cholecystokinin do not promote growth of rat liver. Scand J Gastroenterol 29(8):688–692, 1994

    Google Scholar 

  22. Caplin ME, Savage K, Khan K, Varro A, Michaeli D, Pounder RE, Dhillon AP: Expression and processing of gastrin in patients with hepatocellular carcinoma, fibrolamellar carcinoma and cholangiocarcinoma. J Hepatol 30:519–526, 1999

    Google Scholar 

  23. Glaser S, Benedetti A, Marucci L, Alvaro D, Baiocchi L, Kanno N, Caligiuri A, Phinizy JL, Chowdhury U, Papa E, LeSage E, Alpini G. Gastrin inhibits cholangiocyte growth in bile duct-ligated rats by interaction with cholecystokinin-B/ gastrin receptors via D-myo-inositol 1,4,5–triphosphate-, Ca2+-, and protein kinase C a-dependent mechanisms. Hepatology 32:17–25, 2000

    Google Scholar 

  24. Jessop NW, Hay RJ: Characteristics of two rat pancreatic exocrine cell lines derived from transplantable tumours. In Vitro 16:212, 1980

    Google Scholar 

  25. Blackmore M, Hirst BH: Autocrine stimulation of growth of AR42J rat pancreatic tumour cells by gastrin. Br J Cancer 66(1):32–38, 1992

    Google Scholar 

  26. Watson SA, Michaeli D, Grimes S, Morris TM, Crosbee D, Wilkinson M, Robinson G, Robertson JF, Steele RJ, Hardcastle JD: Anti-gastrin antibodies raised by Gastrimmune inhibit growth of the human colorectal tumour AP5. Int J Cancer 61:233–240, 1995

    Google Scholar 

  27. Hughes J, Boden P, Costall B, Domeney A, Kelley E, Horwell DC, Hunter JC, Pinnock RD, Woodruff GN. Development of a class of selective cholecystokinin type B receptor antagonist having potent anxiolytic activity. Proc Natl Acad Sci USA 87:6728–6732, 1990

    Google Scholar 

  28. Watson SA, Michaeli D, Grimes S, Morris TM, Robinson G, Varro A, Justin TA, Hardcastle JD: Gastrimmune raises anti-bodies that neutralise amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer. Cancer Res 56:880–885, 1996

    Google Scholar 

  29. Watson SA, Morris DL, Durrant LG, Robertson JF, Hardcastle JD: Inhibition of gastrin-stimulated growth of tumour cells by octreotide and the gastrin/ cholecystokinin receptor antagonists, proglumide and lorglumide. Eur J Cancer 28:1462–1466, 1992

    Google Scholar 

  30. Seva C, Scemama JL, Bastie MJ, Prdayrol L, Vaysse N: Lorglumide and loxiglumide inhibit gastrin-stimulated DNA synthesis in a rat tumoral acinar pancreatic cell line (AR42J). Cancer Res 50:5829–5833, 1990

    Google Scholar 

  31. Hoosein NM, Kiener PA, Curry RC: Anti-proliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines. Cancer Res 48:7179–7183, 1988

    Google Scholar 

  32. Kusyk CJ, McNeil NO, Johnson IR: Stimulation of growth of a colon cancer cell line by gastrin. Am J Physiol 251:G597–G601, 1986

    Google Scholar 

  33. Brand SJ, Fuller PJ: Differential gastrin gene expression in rat gastrointestinal tract and pancreas during neonatal development. J Biol Chem 263:5341–5347, 1988

    Google Scholar 

  34. Wang TC, Brand SJ: Islet cell-specific regulatory domain in the gastrin promoter contains adjacent positive and negative DNA elements. J. Biol Chem 265:8908–8914, 1990

    Google Scholar 

  35. Montag AG, Oka T, Baek KH, Choi CS, Jay G, Agarwal K: Tumors in hepatobiliary tract and pancreatic islet tissues of transgenic mice harboring gastrin simian virus 40 large tumor antigen fusion gene. Proc Nat Acad Sci USA 90:6696–6700, 1993

    Google Scholar 

  36. Wang TC, Koh TJ, Varro A, Cahill RJ, Dangler CA, Fox JG, Dockray GJ: Processing and proliferative effects of human progastrin in transgenic mice. J Clin Invest 98:1918–1929, 1996

    Google Scholar 

  37. Watson SA, Durant LG, Morris DL: Growth promoting effect of gastrin on human colonic and gastric tumor cells cultured in vitro. Br J Surg 75:342–345, 1988

    Google Scholar 

  38. Baldwin GS, Zhang QX: Measurement of gastrin and transforming growth factor a messenger RNA levels in colonic carcinoma cell lines by quantitative PCR. Cancer Res 52:2261–2267, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caplin, M., Khan, K., Grimes, S. et al. Effect of Gastrin and Anti-Gastrin Antibodies on Proliferation of Hepatocyte Cell Lines. Dig Dis Sci 46, 1356–1366 (2001). https://doi.org/10.1023/A:1010634031457

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1010634031457

Navigation